文献速递糖尿病

DR9/DR9基因型对1型糖尿病部分缓解频率与质量的不利影响

The Unfavorable Impact of DR9/DR9 Genotype on the Frequency and Quality of Partial Remission in Type 1 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本研究纳入237例1型糖尿病患者,按C肽≥300 pmol/L定义部分缓解,比较不同HLA基因型下部分缓解频率及缓解期峰值C肽。中位随访24个月,65.8%患者进入部分缓解。

要点

  • DR9/DR9携带者部分缓解率显著低于非DR9/DR9携带者(44.2% vs 70.6%)。

核心结论

  • 携带易感DR9/DR9的1型糖尿病患者更不易发生部分缓解。
  • 成人DR9/DR9携带者部分缓解期β细胞功能恢复程度倾向于更低,可能与ZnT8A相关。

研究设计与样本

  • 共纳入237例1型糖尿病患者,按C肽≥300 pmol/L定义部分缓解。
  • 比较不同HLA状态下部分缓解频率及缓解期峰值C肽,并收集起病年龄和糖尿病自身抗体。
  • 所有分析在儿童起病和成人起病1型糖尿病亚组中重复进行。

主要发现

  • 中位随访24个月,65.8%(156/237)的1型糖尿病患者进入部分缓解。
  • DR9/DR9携带者部分缓解期峰值C肽更低,成人起病者更明显。

关键数值与推荐

  • 部分缓解定义为C肽≥300 pmol/L。

临床怎么用

  • 对携带DR9/DR9的1型糖尿病患者,应预期其部分缓解可能性较低且缓解期β细胞功能恢复程度可能更差。
  • 成人起病DR9/DR9携带者监测ZnT8A可能有助于评估部分缓解期β细胞功能恢复情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Partial remission (PR) is a specific stage in type 1 diabetes (T1D). Although human leukocyte antigen (HLA) class II loci are the strongest genetic determinants in T1D, the relationship between PR and HLA remains unclear. OBJECTIVE: To investigate the association between PR status and HLA genotypes in patients with T1D. METHODS: A total of 237 patients with T1D were included. PR was defined according to C-peptide ≥300 pmol/L. The frequency of PR and peak C-peptide levels during remission phase were compared according to HLA status. Clinical characteristics including age of onset and diabetes autoantibodies were collected. All analyses were duplicated when subjects were divided into childhood- and adult-onset T1D. RESULTS: The median follow-up time was 24 months, 65.8% (156/237) of patients with T1D went into PR. DR9/DR9 carriers had a lower PR rate (44.2% vs 70.6%, P = .001) and were less likely to enter PR (OR = 0.218, 95% CI 0.098-0.487, P < .001) than the non-DR9/DR9 carriers, observed in both childhood- and adult-onset T1D. Besides, the peak C-peptide level during PR phase was also lower in DR9/DR9 carriers, and more notable in adult-onset T1D. When compared with non-DR9/DR9 carriers, T1D with DR9/DR9 genotype presented an older age of onset and a lower positivity of zinc transporter 8 antibody (ZnT8A), and the lower trend of ZnT8A was only found in adult-onset T1D (P = .049). CONCLUSION: Patients with T1D carrying susceptible DR9/DR9 are less prone to undergo PR. Additionally, the recovery extent of β-cell function during the PR phase tends to be lower in adults carrying DR9/DR9, which might be associated with ZnT8A.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chen Y, Xia Y, Xie Z, et al. The Unfavorable Impact of DR9/DR9 Genotype on the Frequency and Quality of Partial Remission in Type 1 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 34390338. doi:10.1210/clinem/dgab589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。